immunitoAI
PrivateLast Round
Series A
Nov 26, 2025
Total Funding Raised
$7.16M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
immunitoAI is a biotechnology company that has developed an AI-powered platform for antibody discovery intended to accelerate the development of novel antibody therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
immunitoAI Comparables
Compare immunitoAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 88% | |
| DenovAI Biotech | 86% | |
| Aureka | 85% |
immunitoAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 26, 2025 | ||||
| Seed | Sep 8, 2021 | ||||
| Pre Seed | Nov 1, 2020 |
Key People
Founding team and executive leadership
immunitoAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LetsVenture Online | Series A |
| pi Ventures | Series A, Seed |
| 3one4 Capital | Series A |
| Entrepreneurs First | Seed, Pre Seed |
| AC Ventures | Series A |
| Anicut Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1184% MoM, reaching 16.1K.
- Jun 19, 2026
Monthly visitors grew 111% MoM.
immunitoAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about immunitoAI's valuation, stock price, and market status.
Is immunitoAI a public or private company?
immunitoAI is a private company.
What is the current stock price of immunitoAI?
immunitoAI is a private company, so its shares have no public market price. Caplight tracks immunitoAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is immunitoAI worth (valuation)?
Valuation information for immunitoAI is not publicly available.
Can I buy immunitoAI stock?
immunitoAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was immunitoAI's last funding round?
immunitoAI's most recent funding round was Series A on November 26, 2025.
Who are the main investors in immunitoAI?
Key investors in immunitoAI include pi Ventures, Entrepreneurs First.
Will immunitoAI IPO soon?
No public IPO plans have been announced for immunitoAI.
How can I track immunitoAI secondary market activity?
Caplight tracks bids, offers, and trades in immunitoAI's shares on secondary markets.